Efficacy and Safety of BMS-298585 Alone or in Combination With Pravastatin in Subjects With Mixed Dyslipidemia
Public ClinicalTrials.gov record NCT00245388. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Dose-Ranging, Placebo-Controlled Trial to Determine the Lipid-Lowering Efficacy and Safety of BMS-298585 Alone or in Combination With Pravastatin in Subjects With Mixed Dyslipidemia
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a randomized, double-blind, dose-ranging, placebo-controlled trial to determine the lipid-lowering efficacy and safety of BMS-298585 (muraglitazar) alone in combination with pravastatin in subjects with mixed dyslipidemia.
Study identification
- NCT ID
- NCT00245388
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Enrollment
- 330 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2002
- Primary completion
- Not listed
- Completion
- Jun 30, 2002
- Last update posted
- Apr 22, 2012
2002
United States locations
- U.S. sites
- 53
- U.S. states
- 24
- U.S. cities
- 53
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Local Institution | Phoenix | Arizona | — | — |
| Local Institution | Little Rock | Arkansas | — | — |
| Local Institution | Irvine | California | — | — |
| Local Institution | Long Beach | California | — | — |
| Local Institution | Raleigh | California | — | — |
| Local Institution | Roseville | California | — | — |
| Local Institution | Sacramento | California | — | — |
| Local Institution | San Diego | California | — | — |
| Local Institution | Santa Ana | California | — | — |
| Local Institution | Longmont | Colorado | — | — |
| Local Institution | Clearwater | Florida | — | — |
| Local Institution | Cooper City | Florida | — | — |
| Local Institution | DeLand | Florida | — | — |
| Local Institution | Inverness | Florida | — | — |
| Local Institution | Longwood | Florida | — | — |
| Local Institution | Pembroke Pines | Florida | — | — |
| Local Institution | Sarasota | Florida | — | — |
| Local Institution | Stuart | Florida | — | — |
| Local Institution | Dunwoody | Georgia | — | — |
| Local Institution | Melbourne | Georgia | — | — |
| Local Institution | Peoria | Illinois | — | — |
| Local Institution | Indianapolis | Indiana | — | — |
| Local Institution | Iowa City | Iowa | — | — |
| Local Institution | Overland Park | Kansas | — | — |
| Local Institution | Wichita | Kansas | — | — |
| Local Institution | Louisville | Kentucky | — | — |
| Local Institution | Marrero | Louisiana | — | — |
| Local Institution | Baltimore | Maryland | — | — |
| Local Institution | Bethesda | Maryland | — | — |
| Local Institution | Edina | Minnesota | — | — |
| Local Institution | Minneapolis | Minnesota | — | — |
| Local Institution | Kansas City | Missouri | — | — |
| Local Institution | St Louis | Missouri | — | — |
| Local Institution | Toms River | New Jersey | — | — |
| Local Institution | Manlius | New York | — | — |
| Local Institution | Hickory | North Carolina | — | — |
| Local Institution | Winston-Salem | North Carolina | — | — |
| Local Institution | Columbus | Ohio | — | — |
| Local Institution | Bend | Oregon | — | — |
| Local Institution | Hillsboro | Oregon | — | — |
| Local Institution | Portland | Oregon | — | — |
| Local Institution | Philadelphia | Pennsylvania | — | — |
| Local Institution | Sellersville | Pennsylvania | — | — |
| Local Institution | Warminster | Pennsylvania | — | — |
| Local Institution | Greer | South Carolina | — | — |
| Local Institution | Mt. Pleasant | South Carolina | — | — |
| Local Institution | Austin | Texas | — | — |
| Local Institution | Dallas | Texas | — | — |
| Local Institution | San Angelo | Texas | — | — |
| Local Institution | San Antonio | Texas | — | — |
| Local Institution | Olympia | Washington | — | — |
| Local Institution | Seattle | Washington | — | — |
| Local Institution | Yakima | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00245388, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 22, 2012 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00245388 live on ClinicalTrials.gov.